The stock of Hepion Pharmaceuticals Inc. (HEPA) has seen a 100.21% increase in the past week, with a 0.52% gain in the past month, and a -3.60% decrease in the past quarter. The volatility ratio for the week is 31.69%, and the volatility levels for the past 30 days are at 16.22% for HEPA. The simple moving average for the past 20 days is 21.08% for HEPA’s stock, with a 17.03% simple moving average for the past 200 days.
Is It Worth Investing in Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) Right Now?
while the 36-month beta value is 1.67.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The average price point forecasted by analysts for Hepion Pharmaceuticals Inc. (HEPA) is $44.00, which is $33.93 above the current market price. The public float for HEPA is 3.81M, and currently, short sellers hold a 0.90% ratio of that floaft. The average trading volume of HEPA on May 25, 2023 was 322.06K shares.
HEPA) stock’s latest price update
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) has experienced a decline in its stock price by -12.20 compared to its previous closing price of 16.03. However, the company has seen a gain of 100.21% in its stock price over the last five trading days.
HEPA Trading at 5.19% from the 50-Day Moving Average
After a stumble in the market that brought HEPA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.00% of loss for the given period.
Volatility was left at 16.22%, however, over the last 30 days, the volatility rate increased by 31.69%, as shares surge +3.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.58% lower at present.
During the last 5 trading sessions, HEPA rose by +100.21%, which changed the moving average for the period of 200-days by -2.26% in comparison to the 20-day moving average, which settled at $11.65. In addition, Hepion Pharmaceuticals Inc. saw 134.35% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for HEPA
Equity return is now at value -99.90, with -78.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 7.16.
Conclusion
In a nutshell, Hepion Pharmaceuticals Inc. (HEPA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
